The Evolving Role of Genotypic Data

Ruben A. Mesa, MD

Video Categories: Myelofibrosis

Dr. Mesa recognizes that although genotypic data is not yet being used to select treatment choice or dosing in myelofibrosis, it is used to address the issues of prognosis and burden of disease.
October 14, 2014

Useful Patient Tools Available for Patients with Polycythemia Vera

Dr. Michaelis discusses useful tools in her experience for treatment of polycthemia vera.Supported through funding from Incyte

January 16, 2019

Navigating the CMS 14-Day Rule in Biomarker Testing

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.